Quel impact de la congélation ovocytaire par vitrification sur l’épigénétique ? (notice n° 755958)
[ vue normale ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02595cam a2200349 4500500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250123100308.0 |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | fre |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | dc |
| 100 10 - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Barberet, Julie |
| Relator term | author |
| 245 00 - TITLE STATEMENT | |
| Title | Quel impact de la congélation ovocytaire par vitrification sur l’épigénétique ? |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Date of publication, distribution, etc. | 2019.<br/> |
| 500 ## - GENERAL NOTE | |
| General note | 12 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Résumé Les enfants conçus par les technologies d’assistance médicale à la procréation (AMP) ont un risque modéré de présenter un certain nombre d’effets indésirables et de pathologies. Il n’est toujours pas établi si ce risque supplémentaire est associé à des procédures spécifiques utilisées en AMP ou aux facteurs biologiques intrinsèques rattachés à l’infertilité. L’une des principales hypothèses est que les procédures de laboratoire pourraient avoir une action sur l’épigénome des gamètes et de l’embryon. Cette suspicion est liée au fait que les procédures d’AMP interviennent précisément pendant la période où de grands remaniements se produisent au niveau de l’organisation de cet épigénome. Cet article présente les travaux qui ont étudié l’impact de la congélation ovocytaire par vitrification sur la régulation épigénétique. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Children conceived by assisted reproductive technologies (ART) have an increased risk of adverse effects and diseases. It is still unresolved whether the ART procedures or infertility/subfertility status of the parents might explained some of these changes. The hypothesis is that ART procedures themselves can induce adverse epigenetic effects, especially because they take place at times when maximal epigenetic reprogramming is occurring, including during female gametogenesis and after fertilization. In this manuscript we will present the main results of the studies assessing the epigenetic impact after oocyte vitrification. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | épigénome |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vitrification |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | congélation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | ovocyte |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | oocyte |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | vitrification |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | cryopreservation |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) | |
| Topical term or geographic name as entry element | epigenome |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Barry, Fatima |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bruno, Céline |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Guilleman, Magali |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lieury, Nicolas |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Choux, Cécile |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sagot, Paul |
| Relator term | author |
| 700 10 - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fauque, Patricia |
| Relator term | author |
| 786 0# - DATA SOURCE ENTRY | |
| Note | Médecine de la Reproduction | 21 | 4 | 2019-10-01 | p. 288-294 | 2650-8427 |
| 856 41 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://shs.cairn.info/revue-medecine-de-la-reproduction-2019-4-page-288?lang=fr&redirect-ssocas=7080">https://shs.cairn.info/revue-medecine-de-la-reproduction-2019-4-page-288?lang=fr&redirect-ssocas=7080</a> |
Pas d'exemplaire disponible.
Réseaux sociaux